Skip to main content

Table 1 Baseline characteristics of children receiving first-line NNRTI-based HAART

From: Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children

Characteristics* N  
Age, years 107 6.2(4.2-8.9)
Female,% 107 52.3
CDC clinical classification N:A:B:C,% 107 4:44:30:22
Weight for age z-score 107 -1.5(-2.4 to -0.4)
Height for age z-score 107 -1.7(-2.6 to -1.1)
Weight for height z-score 107 -0.5(-1.6 to 0.3)
Hemoglobin, g/dL 78 10.6(9.5-11.7)
CD4% 101 7(3-15)
CD4 count, cells/mm3 101 151(35-477)
HIV-RNA log10 copies/ml 100 5(4.9-5.5)
NVP:EFV-based HAART,% 107 70:30
  1. CDC: Center for Disease Control and Prevention, NVP: nevirapine, EFV: efavirenz,
  2. HAART: highly active antiretroviral therapy
  3. *Data was shown in median (IQR) or percentage